{"id":1020299,"date":"2026-11-12T09:34:23","date_gmt":"2026-11-12T14:34:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/"},"modified":"2026-11-12T09:34:23","modified_gmt":"2026-11-12T14:34:23","slug":"cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/","title":{"rendered":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16"},"content":{"rendered":"

\nCompany to report third quarter 2026 financial results and host conference call at 8:30 a.m. ET
\n<\/h2>\n
\n

HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Cerenome, Inc. (Nasdaq: CNSY) (\u201cCerenome\u201d or the \u201cCompany\u201d),<\/strong> a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today announced it will host a conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time to review REYOBIQ ReSPECT-LM clinical data scheduled for presentation at SNO on November 13 and provide a CNSide\u00ae commercial update. The Company will also report its third quarter 2026 financial results that day.<\/p>\n\n\n\n\n\n\n\n\n
\n Webcast and Conference Call<\/strong>\n <\/td>\n<\/tr>\n
Date\/Time:<\/td>\nMonday, November 16, 2026, at 8:30 AM ET<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=vTAb1pUs<\/a>\n <\/td>\n<\/tr>\n
Dial-in:<\/td>\nU.S.: 833-862-0853<\/td>\n<\/tr>\n
\u00a0<\/td>\nInternational: 412-365-5147<\/td>\n<\/tr>\n
\u00a0<\/td>\nPlease dial in 15 minutes prior to the start time.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

Following the live call, a replay will be available on the Company\u2019s website under the \u2018For Investors\u2019 section. The webcast will be available on the Company\u2019s website for 90 days.<\/p>\n

\n About Cerenome
<\/strong>Cerenome (Nasdaq: CNSY) is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The CNSide\u00ae CSF diagnostics platform combines cellular and molecular testing to support the detection, characterization, and longitudinal assessment of cancers involving the CNS.\u00a0<\/p>\n

Its lead therapeutic platform, REYOBIQ\u2122 (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.\u00a0<\/p>\n

By integrating commercial diagnostics, targeted therapeutics, proprietary longitudinal data, and artificial intelligence within a single organization, Cerenome is building a differentiated CNS oncology platform designed to improve patient care while creating long-term shareholder value. For more information, visit https:\/\/www.cerenome.com<\/a>.<\/p>\n

\n Investor Contact<\/strong>
\n
CORE IR
IR@cerenome.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to report third quarter 2026 financial results and host conference call at 8:30 a.m. ET HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Cerenome, Inc. (Nasdaq: CNSY) (\u201cCerenome\u201d or the \u201cCompany\u201d), a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today announced it will host a conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time to review REYOBIQ ReSPECT-LM clinical data scheduled for presentation at SNO on November 13 and provide a CNSide\u00ae commercial update. The Company will also report its third quarter 2026 financial results that day. Webcast and Conference Call Date\/Time: Monday, November 16, 2026, at 8:30 AM ET Webcast: https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=vTAb1pUs Dial-in: U.S.: 833-862-0853 \u00a0 International: 412-365-5147 \u00a0 Please dial in 15 minutes prior … <\/p>\n

Continue reading “Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1020299","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to report third quarter 2026 financial results and host conference call at 8:30 a.m. ET HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Cerenome, Inc. (Nasdaq: CNSY) (\u201cCerenome\u201d or the \u201cCompany\u201d), a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today announced it will host a conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time to review REYOBIQ ReSPECT-LM clinical data scheduled for presentation at SNO on November 13 and provide a CNSide\u00ae commercial update. The Company will also report its third quarter 2026 financial results that day. Webcast and Conference Call Date\/Time: Monday, November 16, 2026, at 8:30 AM ET Webcast: https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=vTAb1pUs Dial-in: U.S.: 833-862-0853 \u00a0 International: 412-365-5147 \u00a0 Please dial in 15 minutes prior … Continue reading "Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-12T14:34:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16\",\"datePublished\":\"2026-11-12T14:34:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/\"},\"wordCount\":326,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/\",\"name\":\"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=\",\"datePublished\":\"2026-11-12T14:34:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/","og_locale":"en_US","og_type":"article","og_title":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk","og_description":"Company to report third quarter 2026 financial results and host conference call at 8:30 a.m. ET HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Cerenome, Inc. (Nasdaq: CNSY) (\u201cCerenome\u201d or the \u201cCompany\u201d), a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today announced it will host a conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time to review REYOBIQ ReSPECT-LM clinical data scheduled for presentation at SNO on November 13 and provide a CNSide\u00ae commercial update. The Company will also report its third quarter 2026 financial results that day. Webcast and Conference Call Date\/Time: Monday, November 16, 2026, at 8:30 AM ET Webcast: https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=vTAb1pUs Dial-in: U.S.: 833-862-0853 \u00a0 International: 412-365-5147 \u00a0 Please dial in 15 minutes prior … Continue reading \"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-12T14:34:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16","datePublished":"2026-11-12T14:34:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/"},"wordCount":326,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/","name":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=","datePublished":"2026-11-12T14:34:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NjAxMiM3OTYxNTMwIzIwMDQ4MDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerenome-to-review-reyobiq-respect-lm-data-presented-at-sno-conference-and-provide-cnside-commercial-update-on-november-16\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1020299"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020299\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1020299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1020299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1020299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}